Substantia Nigra Echogenicity Signal Correlated with Clinical Features in Patients with Parkinson’s Disease in Xinjiang

Table 5

Analysis of factors influencing UPDRS 3.0 II scores of PD patients.

Clinical features	Single-factor analysis		Multifactor analysis
	value	value	value	value
SNH (cm^2)	0.261 (2.561, 10.440)	0.001	0.048 (−2.729, 5.647)	0.487
Course of disease	0.292 (0.288, 0.961)	<0.001	0.160 (−0.044, 0.915)	0.074
Urination disorder (reference: no)	0.241 (1.363, 6.766)	0.003	0.051 (−1.916, 3.770)	0.516
Constipation (reference: no)	0.179 (0.299, 6.054)	0.031	0.048 (−1.974, 3.777)	0.532
Cognitive impairment (reference: no)	0.415 (4.604, 10.323)	<0.001	0.048 (−4.257, 6.089)	0.724
UPDRS3.0 I	0.567 (1.170, 2.245)	<0.001	0.085 (−0.310, 0.933)	0.319
UPDRS3.0 III	0.743 (0.404, 0.592)	<0.001	0.433 (0.154, 0.409)	<0.001
UPDRS3.0 IV	0.426 (0.821, 2.258)	<0.001	0.014 (−0.574, 0.677)	0.869
H-Y staging	0.460 (2.694, 5.317)	<0.001	0.223 (0.365, 4.178)	0.020
MoCA	−0.454 (−0.906, −0.400)	<0.001	0.028 (−0.350, 0.444)	0.813